Influenza Flu Shot Vaccine 2024 - 2025 Afluria Trivalent Multiple-Dose Vial 5 mL **Refrigeration Required**

The Flu Shot Vaccine 2024-2025 Afluria Trivalent Multiple-Dose Vial 5 mL is designed to protect against three strains of the influenza virus, prevalent for the 2024-2025 flu season. Administered in a healthcare setting, it helps prevent seasonal flu and its complications, safeguarding public health. This trivalent formulation is suitable for adults and children above a certain age, offering immunity enhancement for better influenza management. Annual vaccination is recommended to maintain effective protection as the virus evolves.

Prepare for the flu season with the Afluria Trivalent Influenza Vaccine for 2024-2025 by Seqirus, crafted with care and precision to protect against the most prevalent influenza strains. This multiple-dose vial is an essential tool in the fight against influenza, aiming to minimize the impact of seasonal flu outbreaks. Trusted by healthcare professionals worldwide, Afluria is designed to offer broad protection and is particularly suitable for use in both individual and community immunization programs.

Details and Features

• Trivalent Vaccine: Protects against three significant influenza virus strains: two influenza A strains and one influenza B strain, selected based on global surveillance.
  
• Multiple-Dose Vial: The 5 mL vial delivers efficient immunization for large groups, ensuring easy administration in clinical settings.
  
• Designed for Specific Flu Season: Tailored for optimal protection during the 2024-2025 flu season, based on expert predictions of the most likely circulating strains.
  
• Suitable for Various Age Groups: Recommended for individuals according to prescribing information, typically healthy adults and certain children, ensuring broad demographic use.
  
• Seqirus Quality: Manufactured by Seqirus, a leading name in vaccine development, ensuring high quality and rigorous testing.

Mechanism of Action

The Afluria Trivalent Influenza Vaccine functions by stimulating the immune system to produce antibodies against the influenza viruses. Once vaccinated, the body identifies and combats the influenza virus swiftly upon exposure, reducing the risk of illness. The vaccine contains inactivated (killed) virus particles that cannot cause the disease but are sufficient to trigger an immune response.

Directions for Use

1. Consultation: Prior to vaccination, consult with a healthcare professional to confirm suitability, especially in individuals with pre-existing health conditions.
2. Preparation: Shake the vial well before use to ensure proper suspension of the vaccine.
3. Dosage & Administration: Administered intramuscularly by a professional. Dose varies depending on age and health guidelines, typically 0.5 mL per adult or as otherwise directed by a healthcare provider.
4. Follow Safety Protocols: Maintain aseptic technique to prevent contamination during transfer from vial to syringe.

Warnings

• Hypersensitivity: Immediate hypersensitivity reactions, including anaphylaxis, can occur. Do not administer to individuals with a history of severe allergic reactions to any component of the vaccine, including egg protein.
  
• Vaccination Conditions: Postpone vaccination in cases of moderate to severe acute illness.
  
• Age and Dosage Restrictions: Follow age-appropriate vaccination schedules and doses as specified by healthcare authorities.
  
• Not For Ill Individuals: If symptoms of a cold or fever are present, reschedule the vaccination for when the individual is healthy.

Side Effects

Common side effects may include:

• Mild Reactions: Soreness, redness, or swelling at the injection site, mild fever, headache, muscle aches, or fatigue.
  
• Systemic Reactions: Low-grade fever, chills, or general discomfort.
  
• Serious Reactions: Immediate medical attention should be sought if symptoms of an allergic reaction occur, such as hives, swelling, dizziness, or difficulty breathing.

Regular monitoring and consultation with a healthcare provider is advised to manage and understand any side effects and ensure the best protective outcome with the Afluria Trivalent Influenza Vaccine. Embrace this crucial proactive measure against the flu with confidence and resilience.